Mercer Global Advisors’s Arvinas ARVN Stock Holding History

Mercer Global Advisors’s Portfolio ARVN Stock Details ARVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$132K	Buy	15,935 +3,689	+30%	+$34.4K	﹤0.01%	3364
2026 Q1	$130K	Buy	+12,246	New	+$152K	﹤0.01%	2956

Other funds holding ARVN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Pfizer New York $170M AUM 191.09% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mercer Global Advisors's ARVN Position: Q2 2026 in Review

Mercer Global Advisors increased its Arvinas (ARVN) stake by 30% in Q2 2026, buying an estimated $34.4K and bringing the position to 15,935 shares worth $132K. The position accounts for ﹤0.01% of the portfolio, ranked #3364.

Mercer Global Advisors first reported a position in ARVN in Q1 2026 and has held it in 2 quarters since. 201 funds tracked by Wall St. Rank hold ARVN as of Q2 2026.

Mercer Global Advisors held 15,935 shares of Arvinas worth $132K as of Q2 2026.
Mercer Global Advisors bought 3,689 Arvinas shares in Q2 2026, an estimated $34.4K.
Arvinas made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #3364 holding.
Mercer Global Advisors first reported a position in Arvinas in Q1 2026 and has held it in 2 quarters since.
201 funds tracked by Wall St. Rank held Arvinas as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.